Heavy Drinking Can Damage Every Part of the Eye
Jun 24, 2022 · Tori Rodriguez, MA, LPC, AHC, is an Atlanta-based journalist, licensed psychotherapist, and Ayurvedic health coach, creator of the body-positive wellness company …
Generic Latanoprost Receives FDA Approval for Glaucoma, OHT ...
Dec 4, 2024 · The Food and Drug Administration (FDA) has approved a generic latanoprost, a prostaglandin analogue, for the treatment of open-angle glaucoma and ocular hypertension, …
Photobiomodulation Treatment for Dry AMD Approved By FDA ...
Nov 15, 2024 · A photobiomodulation therapy device has received approval by the US Food and Drug Administration (FDA) to be marketed for the treatment of nonexudative (dry) age-related …
ADHD and Vision Disorders Have Pathogenic, Behavioral Links
Nov 10, 2024 · The study analyzed medical records of 940,763 individuals and found that ADHD was more prevalent among people with keratoconus compared with among the whole cohort …
Ocular Myasthenia Gravis Treatment Options Explained
Jul 20, 2023 · Myasthenia gravis (MG) can occur in 2 forms: a generalized myasthenia gravis (GMG) or purely ocular myasthenia gravis (OMG). Ocular myasthenia gravis is characterized …
Mannitol Effectively Lowers Intraocular Pressure - Ophthalmology …
Aug 12, 2024 · Intravenous mannitol significantly lowers intraocular pressure (IOP) in both vitrectomized and non-vitrectomized eyes, according to research published in the American …
Curcuma-Based Nutritional Supplements Reduce AMD Risks
Oct 28, 2024 · A subgroup analysis exploring the supplement’s ability to limit disease progression risk revealed that patients with early nonexudative AMD were less likely to progress to …
GLP-1R Agonists Therapy May Slightly Decrease IOP
Sep 18, 2024 · Glucagon-like peptide-1 receptor (GLP-1R) agonist therapy used for the treatment of diabetes is significantly associated with a small decrease in intraocular pressure (IOP), …
FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis
Dec 19, 2024 · HealthDay News — The U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients …
Photobiomodulation: An Emerging Dry AMD Treatment
Mar 20, 2024 · A Future in AMD Management. There are some limitations in comparing these results to other photobiomodulation studies, including varying wavelengths, time intervals of …